MicroCapClub

About MicroCapClub

MicroCapClub is an exclusive forum for experienced microcap investors focused on microcap companies (sub $500m market cap) trading on United States, Canadian, European, and Australian markets. MicroCapClub was created to be a platform for experienced microcap investors to share and discuss stock ideas. Since 2011, our members have profiled 900+ microcap companies. Investors can join our community by applying to become a member or subscribing to gain instant view only access. MicroCapClub’s mission is to foster the highest quality microcap investor Community.

Publisher

MicroCapClub

Category

business

Language

en

Explicit

No

First episode

31 Aug 2024

Latest episode

7 Oct 2026

Latest episodes

127 episodes in the feed.

1. 

   7 Oct 2026

   From Speculation to Investment by Ian Cassel

   In this episode, Ian Cassel talks about crossing the chasm of speculation to investment in microcap stocks. You can also read it as an article here: https://microcapclub.com/newsletter/ (https://www.youtube.com/redirect?event=video_description&redir_token=QUZZTVljSG05cnA3dXFoWUpEX2FjSFB0TGpESXxBSTVJdTV0OUhQUE1scXZ4STFUdWc2WlAzNkI2UXlCN2pXVGZiVHpWTEZzaks5N05sVFU1bXBBWVdZcUJfdndEOHE1ZW1aNVpkT2JpSjR4TUFZNXJ3bnNMUTh5c1Z3MDc1Qlph&q=https://microcapclub.com/newsletter/&v=-iTjqyp0-mo) MicroCapClub is an exclusive forum for experienced microcap investors to share and discuss microcap companies (sub $1 billion market cap) trading on global markets. Since 2011, our members have profiled 1500+ microcap companies, 350+ have turned into multi-baggers. Investors can join our community by applying to become a member or subscribing to gain instant access. For more information, visit https://microcapclub.com/ (https://www.youtube.com/redirect?event=video_description&redir_token=QUZZTVljRmZuMVZZRTBkWkJhOVdac2toa3h5RXxBSTVJdTV0YTVlNzc0VUpiOVpRSWpRSlUtUXB3ZmRrS19uZ0ZycjNHYkpzLXBEcklGQUdvNDRoZl9rbG5mY0lmUktld3l1RE40clNfNGJJQjZNQ1dudFlhaDcwLVdPUG1ndnlv&q=https://microcapclub.com/&v=-iTjqyp0-mo) Disclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

2. 

   5 Oct 2026

   A Decade of Oil and Gas Investing in One Hour | Alejandro Yela

   Alejandro Yela is the founder of Hermit Ventures and the author of The Hermit, a Substack focused on nano- and microcap companies. He began as a debt investor in Latin American oil and gas bonds, later worked in restructuring, project finance, and M&A. This discussion took place live on October 2nd, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/#join In this episode, Alejandro explains how to value an oil producer on its proven (1P) reserves, and why a company's exposure to the oil price depends on whether it extracts, refines, or transports. He walks through his thesis on Computer Modelling Group, the reservoir simulation software company facing pressure from AI while it pursues acquisitions and buybacks. He also explains why he thinks Canadian oil stocks are fully priced after the run in oil, and why he sees more value in oilfield suppliers like OMS Energy. Share your feedback - david@microcapclub.com David’s X (Twitter) - https://x.com/Valuehunte Alejandro's Substack - https://substack.com/@ayela Chapters 00:00 Introduction 02:13 From Latin American Oil Bonds to Canadian Oil 04:50 Investing in Oil Without Exploration Risk 05:53 Why You Need to Be a Specialist to Build Conviction 07:45 How to Value an Oil Company: 1P, 2P and 3P Reserves 10:21 Are Oil Stocks Just a Bet on the Oil Price? 12:29 Why Refining Is Political: The California Example 14:18 Pipelines as Toll Booths 15:19 Canadian Companies With Assets Abroad and Expropriation Risk 17:16 How to Screen for Oil and Gas Ideas 19:55 The Computer Modelling Group Story 22:34 Is AI a Threat to CMG? 23:29 CMG's Organic Revenue Decline 25:04 Cash Flow, Buybacks and Capital Allocation at CMG 26:04 The 15% Free Cash Flow Yield Rule 29:56 What LNG Canada Phase 2 Means for Canadian Gas 34:56 Why He Wouldn't Buy Canadian Oil Right Now 36:53 What Cash-Rich Oilfield Suppliers Should Do With Their Money 37:27 Geopolitical Risk and Surviving the Oil Cycle 40:07 What If the War Lasts 10 Years? 43:10 His Fund, Mandate and Private Investments 46:19 Helping OMS Energy's CEO With Capital Allocation 47:24 Why Private Businesses Trade at a Premium 50:11 Open Questions: High-End Retail and Crocs 52:13 Information as a Moat: Red Violet and Pagaya Disclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

3. 

   30 Sept 2026

   Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up

   In this Business Breakdown, David Barbato and Adam Wilk sit down with Strata Critical Medical’s (SRTA) co-CEO and CFO Will Heyburn and VP of Finance and Investor Relations and CFO of Clinical Services, Mat Schneider. This discussion took place live on September 29th, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/#join Will Heyburn is co-CEO and CFO of Strata Critical Medical (SRTA), which provides air and ground logistics and clinical services to the US organ transplant industry and supports open heart surgeries at more than 250 hospitals. Before Strata, he worked in private equity at RedBird Capital Partners, and he has been part of the transplant business since it started in 2019. He is joined by Mat Schneider, VP of Finance and Investor Relations and CFO of Clinical Services, who spent twelve years on the buy side. ✉️ Share your feedback - david@microcapclub.com ✉️ David’s X (Twitter) - https://x.com/Valuehunte Chapters 00:00 Introduction to Strata and its mission 03:10 Overview of Strata's services in organ transplant 07:00 Strata's role in organ placement and recovery 11:10 Growth in donation after circulatory death and perfusion 12:38 Advancements in matching algorithms and logistics challenges 14:30 Market share, partnerships, and growth opportunities 16:00 Impact of regulatory changes and industry trust 17:28 Acquisition strategy and integration of clinical and logistics services 20:01 Financial performance and growth metrics 21:17 Industry evolution and competitive landscape 24:37 Device agnosticism and future industry trends 26:48 Competitive advantages of Strata's model 29:46 Pricing, RFPs, and market positioning 34:08 Aircraft ownership and logistics infrastructure 38:24 Industry growth outlook and future opportunities 41:26 Penetration of normothermic regional perfusion and clinical growth 43:40 Regulatory environment and trust in the system 46:45 Third-party recovery market share and growth 50:15 Inorganic growth, return thresholds, and strategic fit 57:12 Long-term vision and industry evolution Disclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

Who has been a guest on MicroCapClub

Names identified in recent episode analyses. Showing up to five guests.

• Naveen Prasad
• Michael Liu
• Justin Leger
• Justin Lagier
• Dave Waters

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

4.8 / 5

16 ratings

Spotify

5.0 / 5

17 ratings

Podcast Authority Score: 35 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

50

Social presence

0

YouTube

0

Engagement

51

Contact MicroCapClub

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Yet Another Value Podcast

• 

  Value Hive Podcast

• 

  The Acquirers Podcast

• 

  Planet MicroCap Podcast | MicroCap Investing Strategies

• 

  Behind the Balance Sheet

• 

  Chit Chat Stocks

Questions about MicroCapClub